These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

926 related articles for article (PubMed ID: 34497264)

  • 1. Mesenchymal stem cell therapy for severe COVID-19.
    Shi L; Wang L; Xu R; Zhang C; Xie Y; Liu K; Li T; Hu W; Zhen C; Wang FS
    Signal Transduct Target Ther; 2021 Sep; 6(1):339. PubMed ID: 34497264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19.
    Cheng X; Jiang M; Long L; Meng J
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):948-961. PubMed ID: 34719217
    [No Abstract]   [Full Text] [Related]  

  • 3. Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19.
    Yen BL; Yen ML; Wang LT; Liu KJ; Sytwu HK
    Stem Cells Transl Med; 2020 Oct; 9(10):1163-1173. PubMed ID: 32526079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
    Song N; Wakimoto H; Rossignoli F; Bhere D; Ciccocioppo R; Chen KS; Khalsa JK; Mastrolia I; Samarelli AV; Dominici M; Shah K
    Stem Cells; 2021 Jun; 39(6):707-722. PubMed ID: 33586320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.
    Zayed M; Iohara K
    Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
    Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
    Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics.
    Yadav P; Vats R; Bano A; Bhardwaj R
    Life Sci; 2020 Dec; 263():118588. PubMed ID: 33049279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs.
    Jamshidi E; Babajani A; Soltani P; Niknejad H
    Stem Cell Rev Rep; 2021 Feb; 17(1):176-192. PubMed ID: 33432484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19.
    Cai Q; Yin F; Hao L; Jiang W
    Stem Cells Dev; 2021 May; 30(9):459-472. PubMed ID: 33715385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action.
    Sadeghi S; Soudi S; Shafiee A; Hashemi SM
    Life Sci; 2020 Dec; 262():118493. PubMed ID: 32979360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19.
    Rocha JLM; de Oliveira WCF; Noronha NC; Dos Santos NCD; Covas DT; Picanço-Castro V; Swiech K; Malmegrim KCR
    Stem Cell Rev Rep; 2021 Feb; 17(1):71-93. PubMed ID: 32895900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities.
    Moradinasab S; Pourbagheri-Sigaroodi A; Zafari P; Ghaffari SH; Bashash D
    Int Immunopharmacol; 2021 Aug; 97():107694. PubMed ID: 33932694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells.
    Wang L; Li Y; Xu M; Deng Z; Zhao Y; Yang M; Liu Y; Yuan R; Sun Y; Zhang H; Wang H; Qian Z; Kang H
    Front Immunol; 2021; 12():726909. PubMed ID: 34394132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications.
    Chen L; Qu J; Kalyani FS; Zhang Q; Fan L; Fang Y; Li Y; Xiang C
    Cell Mol Life Sci; 2022 Feb; 79(3):142. PubMed ID: 35187617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.
    Markov A; Thangavelu L; Aravindhan S; Zekiy AO; Jarahian M; Chartrand MS; Pathak Y; Marofi F; Shamlou S; Hassanzadeh A
    Stem Cell Res Ther; 2021 Mar; 12(1):192. PubMed ID: 33736695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Potential of Mesenchymal Stem Cells for the Treatment of Cytokine Storm due to COVID-19.
    Li X; Yan M; Chen J; Luo Y
    Biomed Res Int; 2021; 2021():3178796. PubMed ID: 34840969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of mesenchymal stem cells in the process of treatment and tissue regeneration after recovery in patients with Covid-19.
    Saburi E; Abazari MF; Hassannia H; Mansour RN; Eshaghi-Gorji R; Gheibi M; Rahmati M; Enderami SE
    Gene; 2021 Apr; 777():145471. PubMed ID: 33549712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cell treatment for COVID-19.
    Xu R; Feng Z; Wang FS
    EBioMedicine; 2022 Mar; 77():103920. PubMed ID: 35279630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
    Can A; Coskun H
    Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.